Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
DEI Certificate at the APTA Learning Center

Jan 1, 2023/Resource

This six-part series is an extension from the previous DEI bundle released in 2021.

Walking the Walk of a Change Agent

Aug 4, 2021/Podcast

Change is difficult. Those words ring true for most, even for those who consider themselves "change agents," but change doesn't have to be negative or a struggle. That's what we'll talk about today with Stephanie Kostsuca, PT, DPT.

How to Apply the New CQ Modifier

Mar 1, 2020/Column

Here's information on how to apply the new CQ modifier to denote when outpatient therapy services are furnished in whole or in part by a PTA.

Putting the Fun Into Functional Recovery

Apr 1, 2018/Feature

Do some of your patients resist exercise? Try making it joyful.

I Don’t Care About My Grades

Nov 6, 2019/Podcast

Hannah Belles, SPT, couldn’t shake a poor grade she’d received on an exam. She started to doubt herself. After sharing her story, her perspective shifted. Instead of holding her grades in such high regard, it made more sense to see them as milestones, or as check-in points. Hear her story.

The Ethics of Value-Based Payment in Physical Therapy Models

Jul 1, 2020/Feature

Physical therapy experts take a look at some issues that must be considered in the movement to value-based payment models.

Aetna Launches PTA Differential

Mar 15, 2024/News

After putting the move on hold for three months, the insurer implemented the reduction March 1.

Proposed 2027 Medicare Physician Fee Schedule: What PTs Need to Know, Part 2

Aug 3, 2026/Article

The U.S. Centers for Medicare & Medicaid Services has released the Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. In Part 1 of our recap, we covered how the proposed changes to the practice expense methodology would uniquely benefit physical therapists. In Part 2, we outline CMS' proposed

NIH-Chronic Prostatitis Symptom Index (NIH-CPSI)

Dec 12, 2013/Test & Measure

Target population: Men with prostate problems.